These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 22872649)

  • 1. Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis.
    Jwa HY; Cho YK; Choi EK; Kim HU; Song HJ; Na SY; Boo SJ; Jeong SU; Kim BS; Lee BW; Song BC
    Clin Mol Hepatol; 2016 Mar; 22(1):183-7. PubMed ID: 27044771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of Biejia decoction pill combined with entecavir in the treatment of hepatitis B liver fibrosis/cirrhosis by VCTE.
    Wan L; Hu C; Wang F; Xu K; Li F; He B; Wu Z; Luo L; Wen Z
    Sci Rep; 2023 Nov; 13(1):19616. PubMed ID: 37949927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of an effect of human immunodeficiency virus coinfection on the pharmacokinetics of entecavir in hepatitis B virus-infected patients.
    Zhu M; Bifano M; Xu X; Wang Y; LaCreta F; Grasela D; Pfister M
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2836-41. PubMed ID: 18391039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophilia and hepatology, back to the future.
    Olveira A; Jiménez V
    Rev Esp Enferm Dig; 2024 Apr; 116(4):179-181. PubMed ID: 38450508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum metabolomics characteristics and fatty-acid-related mechanism of cirrhosis with histological response in chronic hepatitis B.
    Fan HN; Zhao ZM; Huang K; Wang XN; Dai YK; Liu CH
    Front Pharmacol; 2023; 14():1329266. PubMed ID: 38178856
    [No Abstract]   [Full Text] [Related]  

  • 6. Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tablet.
    Dai YK; Fan HN; Huang K; Sun X; Zhao ZM; Liu CH
    World J Hepatol; 2023 Sep; 15(9):1043-1059. PubMed ID: 37900214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bibliometric analysis of entecavir for the treatment of cirrhosis in hepatitis B.
    Zhang Y; Zhou Y
    Asian J Surg; 2024 Jun; ():. PubMed ID: 38945772
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?
    Saracco GM; Marzano A; Rizzetto M
    Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of entecavir treatment among nucleos(t)ide-naïve Moroccan patients with chronic hepatitis B.
    Chakkor A; Rouibaa F; Elaboudi S; Aourarh A
    BMJ Open Gastroenterol; 2016; 3(1):e000081. PubMed ID: 27195127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.
    Ridruejo E
    World J Gastroenterol; 2014 Jun; 20(23):7169-80. PubMed ID: 24966587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients.
    Buti M; Morillas RM; Prieto M; Diago M; Pérez J; Solà R; Bonet L; Palau A; Testillano M; García-Samaniego J; Rodríguez M;
    Eur J Gastroenterol Hepatol; 2012 May; 24(5):535-42. PubMed ID: 22382708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entecavir for the treatment of patients with hepatitis B virus-related decompensated cirrhosis.
    Sadler MD; Coffin CS; Lee SS
    Expert Opin Pharmacother; 2013 Jul; 14(10):1363-9. PubMed ID: 23557465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Entecavir: a new hope for the treatment of chronic hepatitis B].
    Calleja JL; Peñas B
    Gastroenterol Hepatol; 2007 May; 30(5):285-93. PubMed ID: 17493440
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and virological response to entecavir in HBV-related chronic hepatitis or cirrhosis: data from the clinical practice in a single-centre cohort.
    Marengo A; Bitetto D; D'Avolio A; Ciancio A; Fabris C; Marietti M; Toniutto P; Di Perri G; Rizzetto M; Marzano A
    Antivir Ther; 2013; 18(1):87-94. PubMed ID: 22872649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline Hepatitis B Virus DNA Level is a Promising Factor for Predicting the 3 (rd) Month Virological Response to Entecavir Therapy: A Study of Strict Defined Hepatitis B virus Induced Cirrhosis.
    Xu Y; Wu XN; Shi YW; Wei W; Yang AT; Sun YM; Zhao WS; You H
    Chin Med J (Engl); 2015 Jul; 128(14):1867-72. PubMed ID: 26168824
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.